期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

诱导性多能干细胞的研究进展 被引量：1

下载PDF
导出
作者 夏海滨 赵俊丽
机构地区 陕西师范大学生命科学学院基因治疗研究室
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2009年第7期575-576,580,共3页 Chinese Journal of Cellular and Molecular Immunology
基金 国家高技术研究发展计划(863)资助项目(2006AA02Z163) 国家自然科学基金资助项目(30872993)
关键词 干细胞 细胞分化 转录因子
分类号 Q291 [生物学—细胞生物学]
  • 相关文献

参考文献20

  • 1Takahashi K,Yamanaka S.Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors[J].Cell,2006,126(4):663-676.
  • 2Okita K,Ichisaka T,Yamanaka S.Generation of germline-competent induced pluripotent stem cells[J].Nature,2007,448(7151):313-317.
  • 3Takahashi K,Tanabe K,Ohnuki M,et al.Induction of pluripotent stem cells from adult human fibroblasts by defined factors[J].Cell,2007,131(5):861-872.
  • 4Yu J,Vodyanik MA,Smuga-Otto K,et al.Induced pluripotent stem cell lines derived from human somatic cells[J].Science,2007,318(5858):1917-1920.
  • 5Nakagawa M,Koyanagi M,Tanabe K,et al.Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts[J].Nat Biotechnol,2008,26(1):101-106.
  • 6Aoi T,Yae K,Nakagawa M,et al.Generation of pluripotent stem cells from adult mouse liver and stomach cells[J].Science,2008,321(5889):699-702.
  • 7Stadtfeld M,Brennand K,Hochedlinger K.Reprogramming of pancreatic beta cells into induced pluripotent stem cells[J].Curr Biol,2008,18(12):890-894.
  • 8Hanna J,Markoulaki S,Schorderet P,et al.Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency[J].Cell,2008,133(2):250-264.
  • 9Eminli S,Utikal JS,Arnold K,et al.Reprogramming of neural progenitor cells into iPS cells in the absence of exogenous Sox2 expression[J].Stem Cells,2008,26(10):2467-2474.
  • 10Kim JB,Zaehres H,Wu G,et al.Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors[J].Nature,2008,454(7204):646-650.

同被引文献24

  • 1Areman EM, Loper K. Cellular therapy: principles, methods, and regulations. Bethesda : AABB, 2009:203-394 ;427-472.
  • 2Hipp J, Atala A. Sources of stem cells for regenerative medicine. Stem Cell Rev, 2008, 4( 1 ) :3-11.
  • 3Kaufman DS. Toward clinical therapies using hematopoietic cells derived from human pluripotent stem cells. Blood, 2009, 114 ( 17 ) :3513-3523.
  • 4Muller R, Lengerke C. Patient-specific plufipotent stem cells: promises and challenges. Nat Rev Endocfinol, 2009,5(4) :195- 203.
  • 5Fujita Y, Rooney CM, Heslop HE. Adoptive cellular immunotherapy for viral diseases. Bone Marrow Transplant, 2008, 41 (2) :193-198.
  • 6Templin C, Kotlarz D, Faulhaber J, et al. Ex vivo expanded hematopoietic progenitor cells improve cardiac function after myocardial infarction : role of beta-catenin transduetion and cell dose. J Mol Cell Cardiol, 2008, 45(3) :394-403.
  • 7Freimark D, Czermak P. CelL-based regeneration of intervertebral disc defects : review and concepts. Int J Artif Organs, 2009, 32 (4) :197-203.
  • 8Giordano A, Galderisi U, Marino IR. From the laboratory bench to the patient' s bedside: An update on clinical trials with mesenchymal stem cells. J Cell Physiol, 2007, 211(I) :27-35.
  • 9Chamberlain G, Fox J, Ashton B, Middleton J. Concise review: Mesenchymal stem cells: Their phenotype, differentiation capacity, immunological features and potential for homing. Stem Cells, 2007, 25:2739-2749.
  • 10Bartmann C, Rohde E, Schallmoser K, et al. Two steps to functional mesenchymal stromal cells for clinical application. Transfusion, 2007, 47:1426-1435.

引证文献1

二级引证文献4

细胞与分子免疫学杂志
2009年 第7期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部